Voyager Therapeutics (VYGR) Tops Q4 EPS by 5c

Voyager Therapeutics (NASDAQ: VYGR) reported Q4 EPS of ($0.46), $0.05 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $15.34 million versus the consensus estimate of $9.19 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• Apple alleges defendant in trade secret case against OpenAI accessed power converter circuit schematic while at OpenAI - legal filing
• Frontier Airlines to return 13 aircraft early, lease 10 new jets
• Red Lake Gold plans private placement to raise up to $375,000